DOPATREE
DRUG SAFETY AND BIOLOGIC SAFETY (PHARMACOVIGILANCE, PV, CLINICAL, POSTMARKETING, SERIOUS ADVERSE EVENT, SAE, IND, 7-DAY, 15-DAY, EXPEDITED, SIDE EFFECTS, ICSR, PSUR, LITERATURE, SURVEILLANCE, E2B, SAFETY REPORTING, DATA, MEDICATION)
DRUG SAFETY AND BIOLOGIC SAFETY / RELATED / US
IMPORTANT MEDICAL EVENTS (IME, DRUG BIOLOGIC SAFETY, MEDWATCH, REPORTING)
IMPORTANT MEDICAL EVENTS / LISTINGS
HEMATOLOGY CONDITIONS-ALL (BLOOD, HAEMATOLOGICAL, HEMATOLOGICAL, BLOOD DYSCRASIAS)
HEMATOLOGY CONDITIONS / TYPES
NON-MALIGNANT HEMATOLOGY CONDITIONS-ALL (HEMATOLOGIC DISORDERS, HEME DISORDERS, BLOOD DISORDERS, DYSCRASIAS, NONCANCEROUS, NONMALIGNANT)
NON-MALIGNANT HEMATOLOGY CONDITIONS / LISTINGS

FACTOR XIII DEFICIENCY (FIBRIN STABILIZING FACTOR DEFICIENCY, F13, DEFICIENCY, LAKI-LORAND FACTOR)

Parents